SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-11-302160
Filing Date
2011-11-08
Accepted
2011-11-08 16:15:50
Documents
10
Period of Report
2011-09-30
Filing Date Changed
2011-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d237175d10q.htm 10-Q 589116
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d237175dex311.htm EX-31.1 6279
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d237175dex312.htm EX-31.2 6255
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d237175dex321.htm EX-32.1 3104
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER d237175dex322.htm EX-32.2 3089
  Complete submission text file 0001193125-11-302160.txt   1777748

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT orex-20110930.xml EX-101.INS 199834
7 XBRL TAXONOMY EXTENSION SCHEMA orex-20110930.xsd EX-101.SCH 9682
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20110930_cal.xml EX-101.CAL 26588
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20110930_lab.xml EX-101.LAB 92591
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20110930_pre.xml EX-101.PRE 60881
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 111188016
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1